News for Avenue Therapeutics, Inc. (ATXI)

Summary On July 11, 2025, Nasdaq Inc (NDAQ) announced the delisting of several companies' securities from the Nasdaq Stock Market. The delisted entities include

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. N

Nasdaq (NDAQ) is set to delist securities from 34 companies due to prolonged suspensions. Delistings impact diverse sectors such as biotech, electric ve

U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down...

Shares of Harrow, Inc. HROW rose sharply in pre-market trading after the company reported fourth quarter and year-end 2024 unaudited preliminary financial resul...

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a strategic transaction involving Avenue Therapeutics Inc (ATXI). The firm reduced its

Significant Transaction by Ikarian Capital, LLC (Trades, Portfolio) On December 31, 2024, Ikarian Capital, LLC (Trades, Portfolio) executed a noteworthy transac

New Jersey-based Nukkleus Inc. (NUKK) is up over 60 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Israel-based Polyrizon Ltd. (PLRZ) is up over 217 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

**media[466685]**

Avenue Therapeutics stock hits 52-week low at $2.17

Avenue Therapeutics grants stock units to top executives

MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

Shares of MIRA Pharmaceuticals, Inc. MIRA rose sharply in today's pre-market trading after company announced it achieved 100% reversal of neuropathic pain with ...

- Last patient visit complete in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data anticipated in second half of...

Loading... Loading... Shares of Clever Leaves Holdings Inc. CLVR fell sharply during Monday's session after the company announced that it will voluntarily deli...

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.